Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $201,734 | 91 | 72.2% |
| Honoraria | $30,650 | 23 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,080 | 4 | 5.8% |
| Food and Beverage | $13,381 | 160 | 4.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $9,400 | 3 | 3.4% |
| Travel and Lodging | $5,800 | 33 | 2.1% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $2,500 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $45,908 | 75 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $41,064 | 25 | $0 (2022) |
| Johnson & Johnson Surgical Vision, Inc. | $36,910 | 18 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $32,312 | 15 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $32,203 | 24 | $0 (2024) |
| Dompe US, Inc. | $22,764 | 30 | $0 (2024) |
| Shire North American Group Inc | $18,547 | 28 | $0 (2018) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $10,125 | 17 | $0 (2024) |
| TearLab Corp | $9,510 | 11 | $0 (2024) |
| ABBVIE INC. | $6,825 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,357 | 31 | Bausch & Lomb Americas Inc. ($18,614) |
| 2023 | $9,862 | 14 | Bausch & Lomb Americas Inc. ($5,369) |
| 2022 | $16,636 | 21 | Bausch & Lomb Americas Inc. ($8,220) |
| 2021 | $31,744 | 54 | Allergan, Inc. ($18,211) |
| 2020 | $110,536 | 62 | Novartis Pharmaceuticals Corporation ($29,488) |
| 2019 | $34,227 | 63 | Dompe US, Inc. ($7,767) |
| 2018 | $20,277 | 42 | Shire North American Group Inc ($10,741) |
| 2017 | $20,907 | 28 | Allergan Inc. ($9,045) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $83.00 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| 11/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Ophthalmology | ||||||
| 11/01/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,075.00 | General |
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $143.53 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Travel and Lodging | In-kind items and services | $56.11 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Alcon Vision LLC | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 10/19/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $70.04 | General |
| Category: Ophthalmology | ||||||
| 10/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $41.66 | General |
| 10/18/2024 | Bausch & Lomb Americas Inc. | — | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $89.97 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $63.04 | General |
| 10/18/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $41.19 | General |
| 10/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/22/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 08/19/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 07/26/2024 | Bausch & Lomb Americas Inc. | — | Consulting Fee | Cash or cash equivalent | $8,075.00 | General |
| 07/23/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 06/10/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,062.50 | General |
| Category: Ophthalmology | ||||||
| 05/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $850.00 | General |
| Category: Ophthalmology | ||||||
| 05/09/2024 | TearLab Corp | ScoutPro Osmolarity System (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: Ophthalmology | ||||||
| 04/19/2024 | Alcon Research LLC | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,571 | 3,354 | $1.2M | $218,822 |
| 2022 | 24 | 2,750 | 3,435 | $1.8M | $266,379 |
| 2021 | 21 | 2,676 | 3,323 | $1.9M | $276,128 |
| 2020 | 21 | 1,749 | 2,247 | $1.4M | $176,561 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 583 | 684 | $270,180 | $72,382 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 197 | 197 | $107,759 | $26,890 | 25.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 107 | 238 | $186,000 | $25,588 | 13.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 131 | 135 | $55,430 | $13,988 | 25.2% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 283 | 593 | $48,626 | $12,937 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 164 | $46,740 | $12,848 | 27.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 35 | 38 | $137,256 | $11,442 | 8.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 92 | 92 | $45,080 | $10,460 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 70 | $38,850 | $9,577 | 24.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 623 | 651 | $113,925 | $8,320 | 7.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $12,600 | $3,304 | 26.2% |
| 68801 | Dilation of tear drainage opening | Office | 2023 | 20 | 46 | $29,900 | $2,985 | 10.0% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 109 | 227 | $53,572 | $2,543 | 4.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 76 | 78 | $12,480 | $2,297 | 18.4% |
| 92025 | Ct scan of cornea | Office | 2023 | 40 | 41 | $7,216 | $1,329 | 18.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 16 | 16 | $4,944 | $878.40 | 17.8% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 46 | 54 | $22,626 | $784.61 | 3.5% |
| 65205 | Removal of foreign body from external eye (conjunctiva) | Office | 2023 | 12 | 12 | $4,824 | $267.60 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 700 | 833 | $321,976 | $86,383 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 231 | 231 | $126,357 | $30,728 | 24.3% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 106 | 263 | $203,825 | $28,261 | 13.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 23 | 32 | $277,856 | $21,060 | 7.6% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 28 | 39 | $281,736 | $19,591 | 7.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 72 | 72 | $50,400 | $12,681 | 25.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 739 | 775 | $135,625 | $9,970 | 7.4% |
About Dr. Christopher Starr, MD
Dr. Christopher Starr, MD is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720076185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Starr, MD has received a total of $279,545 in payments from pharmaceutical and medical device companies, with $35,357 received in 2024. These payments were reported across 315 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($201,734).
As a Medicare-enrolled provider, Starr has provided services to 9,746 Medicare beneficiaries, totaling 12,359 services with total Medicare billing of $937,890. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Cornea and External Diseases Specialist
- Location New York, NY
- Active Since 10/10/2005
- Last Updated 10/11/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1720076185
Products in Payments
- XIIDRA (Drug) $58,698
- Oxervate (Drug) $17,915
- EYSUVIS (Drug) $16,917
- INVELTYS (Drug) $12,250
- CEQUA (cyclosporine ophthalmic solution) 0.09% (Drug) $7,644
- RESTASIS (Drug) $7,438
- TearLab Osmolarity System (Device) $5,458
- Flarex (Drug) $2,992
- VUITY (Drug) $2,839
- MIEBO (Drug) $2,242
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE) (Device) $2,188
- TEARLAB OSMOLARITY SYSTEM (Device) $2,100
- TEPEZZA (Biological) $2,063
- ScoutPro Osmolarity System (Device) $1,952
- CEQUA (Drug) $1,800
- Eye Health (Device) $1,704
- InflammaDry (Device) $1,537
- TYRVAYA (Drug) $1,453
- CE-marked KXLA system (Device) $1,125
- TearCare (Device) $750.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New York
Dr. Tsontcho Ianchulev, M.d. Mph, M.D. MPH
Ophthalmology — Payments: $21.4M
Dr. Nathan Radcliffe, M.d, M.D
Ophthalmology — Payments: $2.2M
Dr. Joshua Young, M.d, M.D
Ophthalmology — Payments: $805,605
Dr. Raymond Fong, M.d, M.D
Ophthalmology — Payments: $581,936
Joseph Panarelli, M.d, M.D
Ophthalmology — Payments: $525,201
David Guyer
Ophthalmology — Payments: $491,407